Concentra Group Holdings Parent, Inc. 8-K

What Happened
Concentra Group Holdings Parent, Inc. filed an 8‑K reporting that Dr. John R. Anderson, Executive Vice President and Chief Medical Officer, notified the company on April 10, 2026 that he will retire effective December 31, 2026. On July 6, 2026, a consulting agreement was signed under which Dr. Anderson will provide part‑time consulting services to Concentra Health Services, Inc. beginning January 1, 2027 through December 31, 2027.

Key Details

• Consulting Agreement term: effective Jan 1, 2027 through Dec 31, 2027; either party may end it with 30 days’ written notice; Concentra can terminate immediately for Cause.
• Work and pay: up to 10 hours per week at $216.00 per hour for clinical strategy, medical affairs, regulatory matters, and related tasks.
• Equity treatment: outstanding unvested restricted stock awards will continue to vest during the consulting term if Dr. Anderson provides services through each vesting date; if he completes the full term (and is not terminated for Cause or voluntarily resigning) 25% of then‑unvested restricted stock will automatically vest. If terminated for Cause or he voluntarily resigns before term end, all unvested equity is forfeited. Vesting is conditioned on execution of a general release at the start and a final release at the end/termination.
• The Consulting Agreement is filed as Exhibit 10.1 to the 8‑K.

Why It Matters
This filing informs investors of a planned leadership change and how the company is managing continuity: Concentra retains Dr. Anderson’s expertise on a part‑time, paid consulting basis after his retirement, limiting immediate operational disruption. The agreement has a modest direct cash cost (hourly consulting fees) but includes equity vesting provisions that affect executive compensation and retention outcomes. Investors should note the timing (retirement Dec 31, 2026; consulting Jan–Dec 2027) and the conditions around equity vesting, which could influence executive incentive alignment and any related dilution timing.